Extended pleurectomy/decortication for malignant pleural mesothelioma: Humanitas’s experience

Giuseppe Mangiameli, Edoardo Bottoni, Emanuele Voulaz, Umberto Cariboni, Alberto Testori, Alessandro Crepaldi, Veronica Maria Giudici, Emanuela Morenghi, Marco Alloisio

Research output: Contribution to journalArticlepeer-review


Background: We analysed a series of malignant pleural mesothelioma (MPM) patients who consecutively underwent extended Pleurectomy/Decortication (eP/D) in a centre with a high level of thoracic surgery experience (IRCCS Humanitas Research Hospital) to explore postoperative morbidity and mortality, pattern of recurrence and survival. Methods: A retrospective analysis was performed on MPM patients underwent eP/D in our centre from 2010 to 2021. All patients were identified from our departmental database. Postoperative complications were scored according to Clavien–Dindo criteria. Survival analysis was performed by the Kaplan–Meier methods and Cox multivariable analysis. Results: Eighty‐five patients underwent extended pleurectomy decortication (eP/D) during study period. Macroscopical residual disease (R2) was reported in one case. A neoadjuvant chemotherapy regiment was administrated in 88% of the surgical cohort. A complete trimodality treatment including induction with platinum agents and pemetrexed, radical cytoreductive surgery and volumetric modulated arc therapy technology (VMAT) could be administered in 63 patients (74%). Postoperative morbidity rate was 54.11%, major complications (defined as Clavien–Dindo ≥3) were reported in 11 patients (12.9%). Thirty‐day mortality and 90‐day mortality were, respectively, 2.35% and 3.53%. Median disease‐free and overall survival were, respectively, 13.7 and 25.5 months. The occurrence of major complications (Clavien–Dindo ≥3), operative time, pT3–T4, pathological node involvement (pN+) were prognostic factors associated with worse survival. Conclusions: In our experience, eP/D is a well‐tolerated procedure with acceptable mortality and morbidity, allowing for the administration of trimodality regimens in most patients. eP/D offered in a multimodality treatment setting have satisfactory long term oncological results. To obtain best oncological results the goal of surgery should be macroscopic complete resection in carefully selected patients (clinical N0).

Original languageEnglish
Article number4968
JournalJournal of Clinical Medicine
Issue number21
Publication statusPublished - Nov 1 2021


  • Extended pleurectomy/decortication (eP/D)
  • Malignant pleural mesothelioma
  • Trimodality treatment

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Extended pleurectomy/decortication for malignant pleural mesothelioma: Humanitas’s experience'. Together they form a unique fingerprint.

Cite this